Re: homeopathy Digest, Vol 7, Issue 121 Message: 1 Subject: [H]Insulin
That line sketch on pancreatinim is pretty comprehensive.
I'll save it for future use.
----- Original Message -----
From: Sarvadaman Oberoi
To: homeopathy (AT) homeolist (DOT) com
Cc: jtikari1224 (AT) airtelbroadband (DOT) in
Sent: Saturday, May 19, 2007 8:43 PM
Subject: Re: homeopathy Digest, Vol 7, Issue 121 Message: 1 Subject: [H] Insulin
"jtikari" <jtikari1224 (AT) airtelbroadband (DOT) in> wrote 18 May 2007 17:34:15
Dr Rosedale MD, or was it Dr. Mercola, said diabetes is not the disease, but a symptom of an oversensitive pancreas.
Does anyone have any idea what would control a runaway pancreas?
Pituitary 6C (balancing potency) for a long duration should help to stabilise pancreatic activity unless other hormonal imbalance exists eg pituitary.
There is no proving of Pancreatinum that I know of but there is a proving of Pancreas suis.
See also extracts.
H 485 FF Ansals Palam Vihar
Gurgaon 122017 INDIA
There are four main types of cells in the islets of Langerhans. They are relatively difficult to distinguish using standard staining techniques, but they can be classified by their secretion:
Name of cells Product % of islet cells Representative function
beta cells Insulin and Amylin 50-80% lowers blood sugar
alpha cells Glucagon 15-20% slowly raises blood sugar if low
delta cells Somatostatin 3-10% inhibit endocrine pancreas
PP cells Pancreatic polypeptide 1% inhibit exocrine pancreas
The function of the pancreas is to produce important hormones including insulsin, glucagon and somatostatin. Insulin also increases the amount of glycogen (stored carbohydrate) in the liver. Insulin and glucagon play a vital role in carbohydrate and lipid metabolism.
There are two main classes of exocrine pancreatic secretions:
Secretion Cell producing it Primary signal
bicarbonate ions Centroacinar cells Secretin
etc.) Basophilic cells CCK
The digestive enzymes are synthesized and secreted from the exocrine acinar cells, whereas bicarbonate is secreted from the epithelial cells lining small pancreatic ducts. In addition to the proteases, lipase (to hydrolyse triglycerides) and amylase, the pancreas produces a host of other digestive enzymes, including ribonuclease, deoxyribonuclease, gelatinase and elastase.
BLACKWOOD A. L., A Manual of Materia Medica Therapeutics and
- An extract obtained from the pancreas, usually that from the hog.
- Homoeo., Triturations of the dry Pancreatin; and dilutions.
- U. S. P., Pancreatinum.
- Of the pure Pancreatin, gr. iij-viij.
- This agent is a combination of several enzymes.
- It is most potent in an alkaline medium, and as a result should not be administered during the active period of stomachic digestion.
- This agent is indicated in intestinal indigestion with pain in the intestinal canal, commencing one hour or more after eating.
- There are eructations of fatty foods, and the passage of fatty undigested food in the stools.
- It is useful in lienteric diarrhoea and in the diarrhoea of children when the stools contain undigested particles of fat.
CLARKE J. H., Dictionary of Practical Materia Medica (c1)
- Extract of Pancreatic and Salivary Glands of Ox or Sheep.
- Diabetes, pancreatic.
- Pancreas, disease of.
- Pancreatinum has been used with success in conditions due to disease or faulty action of the pancreas on the analogy of Thyroidin and the other Sarcodes.
- Burnett says pancreatics are often of great service in gout.
- In action on pancreas and salivary glands, Ir. v., Nux, Puls., Merc., Iod., Jabor., Pilocarpine.
HALE E. M., Special Therapeutics of the new remedies (hl1)
Is supposed to have the power of converting starch into sugar, and to emulsify fat. It assists in the digestion of starch and fat, and is recommended in those cases of dyspepsia or indigestion where the patient can not eat those substances. The dose is the same as Pepsin. It is sometimes combined with that agent. It is often prescribed for the purpose of aiding the digestion and assimilation of Cod-liver oil.
HALE E. M., Special Symptomatology of the New Remedies (hl9)
(inspissated pancratic juice.)
It is a grayish powder; with an odor something like rancid lard.
The pancreas are dissected and macerated in water, acidulated with hydrochloric acid, for about forty-eight hours, then seperated, and the acidulated solution of pancreatine passed through a pulp filter until it is perfectly clear. To this clear solution is then added a saturated solution of chloride of sodium, and allowed to stand until the pancreatine is separated. This is carefully skimmed off and placed upon a muslin filter and allowed to drain, after which it should be washed with a less concentrated solution of chloride of sodium, and then put under the press. When the mass is nearly dry, it is rubbed with a quantity of sugar of milk and dried throughly without heat.
Pepsin, Iris, Pulsatilla, Ptelea, Nux com., etc.
Dyspepsia; when the power of digesting fatty and starchy food is deficient. (clinical experience has proven the medicine to be curative for symptom / condition. )
(See Therapeutics of Pepsin.)
MATHUR K. N., Diabetes Mellitus Its Diagnosis and Treatment (mta2)
Diabetes with lientric diarrhea: Thin diabetics. Panereatic diabetes. (Dr Jousset)
MURPHY R., Homeopathic Remedy Guide (mp4)
Panc. Pancreatinum. Extract of pancreatic glands of Ox or Sheep. Trituration. Historical dose: All potencies.
Pancreatinum has been used with success in conditions due to disease or faulty action of the pancreas on the analogy of Thyroid in and the other Sarcodes. Burnett says Pancreatinum is often of great service in gout. Planets: Jupiter.
Pancreatinum is a combination of several digestive enzymes. It is indicated in intestinal indigestion, pain an hour or more after eating. Lienteric diarrhea. Diabetes, pancreatic. Diarrhea. Mumps. Gout. Pancreas, disease.
(1) In action on pancreas and salivary glands, Ir-v., Nux-v., Puls., Merc., Iod., Jab., Pilo.
O'CONNOR J., The American Homoeopathic Pharmacopoeia (cnj1)
The pancreas is a large gland, situated deep within the abdominal cavity, and whose function consists in the elaboration of a secretion known as the pancreatic juice. The pancreatic juice has the triple property of acting on starch, whether in the raw or boiled state, with great energy, rapidly converting it into grape sugar; of exercising a solvent action upon proteids similar to the action of the gastric juice upon the same bodies, in so far that by it proteids are converted into peptones; and on fats it has a two-fold action in emulsifying them and splitting up neutral fats into their respective acids and glycerine. The active principle is a nitrogenous ferment called pancreatin.
Preparation.-Prof. Scheffer's method, as given in 1875, is as follows: Fresh and finely chopped beef pancreas is macerated for a day in water acidulated with a little hydrochloric acid; the maceration is repeated with water, the strained liquids filtered, neutralized with calcium carbonate, again filtered, and mixed with an equal volume of 95 per cent. alcohol; the precipitate is washed with dilute alcohol, pressed between bibulous paper, and dried at the ordinary temperature.
Properties.-Pancreatin prepared after Scheffer's formula is a yellow transparent mass, which is quite brittle, and looks like albumen dried after solution. It dissolves slowly in water, but not quite completely, and gives a pale yellow solution which is transparent, and neutral to test-paper. It is precipitated by alcohol and by heating, and also by hydrochloric acid; it remains clear when treated with a saturated solution of sodium chloride.
Preparation.-Pure pancreatin is triturated, as directed under Class VII.
PAVRI KEKI R. S., Essentials of Diabetes Mellitus and Its Treatment by Homoeopathy (pks1)
(extract of pancreatic glands of ox or sheep)
An organ remedy; has been used with success in conditions due to disease or faulty action of the Pancreas, i.e. secondary Diabetes.
VARMA P. N. and INDU V., Encyclopaedia of Homoeopathic Pharmacopoeia (vma2)
Uses: Diabetes, pancreatic. Diarrhoea. Mumps. Gout , disease of pancreases.
Synonyms: French: Pancreatine.
Description: A substance from the fresh pancreas of the domestic pig or cow. It contains several enzymes, principally amylase, lipase, and protease, and is capable of hydrolyzing fats to glycerol and fatty acids, changing protein into proteoses and derived substances, and converting starch into dextrins and sugars. Its greatest activity is exhibited in neutral or faintly alkaline media; more than traces of mineral acids, or large amounts of alkali hydroxides or alkali carbonates render it inactive. The isolated pancreatin is a cream-coloured, amorphous powder, having a faint, characteristic odour. It is partly soluble in water, and insoluble in alcohol.
History and authority: Clarke: Dictionary of Pract. Mat. Med. Vol. II, III.
Trituration 1x Drug Strength 1/10
Pancreatinum 100 g
Saccharum Lactis 900 g
To make one Kilogramme of the Trituration.
b) Potencies: 2x and higher to be triturated. 6x may be converted to liquid 8x. 9x and higher with Dispensing Alcohol.
Storage: Protect from moisture. Should be kept in well close container.
Prescribed dose: 1x and higher.
Note: Enzymatic activity is lost if stored for long.
RILEY D., Collected Provings (rly4)
Symptoms noted by the subjects are organized in the traditional Materia Medica format (as found in Boericke) as well as repertory rubrics according to the system found in Kent or the Complete Repertory. Symptoms are printed in bold or capital letters, italics, or plain type according to criteria mentioned below:
• the symptom occurred shortly after taking the medication,
• the intensity of the symptom,
• the duration of the symptom,
• the number of subjects experiencing a symptom,
• the modalities and concomitants associated with a symptom,
• the symptom was strange, rare, or peculiar, either in general or for that subject.
Clinical trial design
Homeopathic drug provings are not mentioned in the Good Clinical Practice guidelines. They are similar to Phase I clinical trials outlined in the Code of Federal Regulation (CFR) and the European Community (EC) guidelines for clinical research.
Proving Director - David Riley, M.D.
Proving Supervisors - Ann Seipt, N.D. and Aimee Zagon, PA-C
Proving Coordinator - Olivia Mason, R.P. T., M.S.
Data collection - Diary/journal format
Study Design - Single group
Method of Blinding - Double-blind
Controls - Intra-individual controls and placebo controls
The medication used in this homeopathic drug proving was prepared by Simile GmbH, as globules in a 12C potency (concentration 1 X 10-24).
There were 17 subjects; 15 women and 2 men ranging in age from 18 to 63 years. 17 subjects received verum, 2 received placebo. There were no dropouts from this homeopathic drug proving.
Subject Inclusion Criteria - each subject:
• was in a general state of good health for that person according to the proving director/supervisor and the subject. A routine evaluation supported this assessment.
• agreed in advance to comply with instructions for keeping a journal. The subject observed and described symptoms experienced from taking a homeopathic medication.
• did not engage in any elective medical treatments (such as surgery or dental procedures) for the duration of the homeopathic drug proving.
• did not undergo any major life changes (moving, getting married or divorced, etc.) and continued the usual habits and patterns of daily life.
• was over the age of 18, competent, and signed the informed consent.
Subject Exclusion Criteria - no subject:
• was in ongoing medical treatment during the homeopathic drug proving,
• had surgery within the past 6 weeks,
• was on prescription medication,
• had taken birth control pills in the past 6 months,
• was pregnant or nursing,
• failed to complete the journal as instructed,
• was under the age of 18 or lacking complete competence.
General drug proving outline
This homeopathic drug proving was conducted in Santa Fe, NM between December and February, 1995. Subjects were recruited by advertisement. All potential subjects attended at least two training sessions, one group session and one individual session, each of which lasted at least one and one-half hours, prior to being accepted into the homeopathic drug proving. Persons were included or excluded according to the criteria listed above in the subject inclusion/exclusion section. A routine evaluation was performed on all persons selected for the homeopathic drug proving. All potential subjects met with the principal investigators for general education about homeopathy and training regarding journal recording during a homeopathic drug proving. Each subject was given a copy of a previously conducted proving to assist him/her in understanding the format of a homeopathic drug proving. All subjects signed an informed consent.
This classical homeopathic drug proving lasted at least 8 weeks per subject. There was a two week pre-proving observation period to establish the baseline rhythm and symptom picture for each subject. This is a single-case study control, comparing symptoms noted during the pre-proving observation period with those experienced after taking the homeopathic medication. Neither the investigators nor the subjects were aware of the substance being proved until after the final report had been written.
The medication was administered 3 times daily (4 globules dissolved sublingually) until the subject developed symptoms or for three days. The globules were allowed to dissolve under the tongue. No globules were taken after the subject began to experience symptoms. If no symptoms occurred in three days, the subject stopped taking the medication and continued recording in their journal. No food was eaten for at least 15 minutes prior to taking the medication and no food was eaten for at least 15 minutes following administration of the medication.
Symptom collection and evaluation
Subjects noted in their journals the symptoms associated with the administration of the homeopathic medication for one month following the administration of the medication. The symptoms experienced after the administration of the medication were compared with symptoms noted during the pre-proving observation period and were evaluated according to the criteria listed at the beginning of the article. Placebo symptoms are included in the final report and denoted by the letter "P". All subjects completed an exit interview where each symptom experienced was reviewed once again for additional clarification. All symptoms were noted for being either new symptoms, old symptoms, or altered symptoms. Some subjects experienced a relief of chronic symptoms (such as the clearing of a chronically stuffy nose.) There were no adverse effects noted at the time of the exit interview or during the post-proving observation period.
Confusion, difficulty concentrating, mental dullness. Many dreams. VIVID DREAMS.
Lassitude, worse in the morning. Symptoms worse on the left side.
HEAD PAIN, WORSE IN THE MORNING ON WAKING AND WORSE IN THE FOREHEAD. Dull, throbbing, head pain.
Dryness of the eyes, worse on the left side.
Pain and itching in the ear, worse on the left side.
Dryness in the mouth. aphthae.
Pain, worse in the left jaw.
SCRATCHING THROAT PAIN, worse on empty swallowing
Diminished appetite. Painful burping with no food in the stomach.
Severe, cramping abdominal pain. Associated with diarrhea and worse before and after stools.
CONSTIPATION WITH STRAINING.
Hard stools, like balls. Soft stools.
Strong, green urine.
Short scanty menses. Vulvar pain.
Difficult breathing, associated with wheezing. Worse in the daytime.
Chest pain with constriction, worse in the upper chest and under the sternum.
Back pain in general. Aching pain.
Aching pain in the lower limbs, particularly the ankle and foot. Perspiration in the folds of the joints.
Waking, from sleep with the desire to urinate. Sleeplessness with difficulty in falling to sleep.
|Thread Tools||Search this Thread|
|Thread||Thread Starter||Forum||Replies||Last Post|
|RE: homeopathy Digest, Vol 7, Issue 64||R Steele||Homeopathy List Discussion||0||19th March 2007 06:35 AM|
|Re: homeopathy Digest, Vol 7, Issue 41||Ananda Rucira||Homeopathy List Discussion||0||19th February 2007 06:35 PM|
|Re: homeopathy Digest, Vol 6, Issue 351 message 6 PUO in calcutta,india||Sarvadaman Oberoi||Homeopathy List Discussion||0||11th December 2006 01:45 PM|
|Re: homeopathy Digest, Vol 6, Issue 340||Janice Hughlett||Homeopathy List Discussion||1||1st December 2006 01:18 PM|
|RE: homeopathy Digest, Vol 6, Issue 221||Roger||Homeopathy List Discussion||0||15th July 2006 05:15 AM|